BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yi PS, Wang H, Li JS. Evolution and current status of the subclassification of intermediate hepatocellular carcinoma. World J Gastrointest Surg 2020; 12(3): 85-92 [PMID: 32218891 DOI: 10.4240/wjgs.v12.i3.85]
URL: https://www.wjgnet.com/1948-5182/full/v12/i3/85.htm
Number Citing Articles
1
Jie Zan, Xuya Zhao, Xiya Deng, Hongda Ding, Bi Wang, Minyi Lu, Zijing Wei, Zhi Huang, Shuai Wang. Paraspeckle Promotes Hepatocellular Carcinoma Immune Escape by Sequestering IFNGR1 mRNACellular and Molecular Gastroenterology and Hepatology 2021; 12(2): 465 doi: 10.1016/j.jcmgh.2021.02.010
2
Yuehui Liang, Qi Liang, Liang Qiao, Fang Xiao. MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular CarcinomaFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00920
3
Masateru Yamamoto, Tsuyoshi Kobayashi, Masakazu Hashimoto, Shintaro Kuroda, Tomokazu Kawaoka, Hiroshi Aikata, Kazuaki Chayama, Hideki Ohdan. Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassificationBMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08421-3
4
Hee Ho Chu, Jin Hyoung Kim, Ju Hyun Shim, Dong Il Gwon, Heung-Kyu Ko, Ji Hoon Shin, Gi-Young Ko, Hyun-Ki Yoon, Nayoung Kim. Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular CarcinomaCancers 2021; 13(11): 2830 doi: 10.3390/cancers13112830